Dual therapy with a boosted protease inhibitor plus lamivudine is an effective maintenance strategy in patients on second-line antiretroviral therapy in Africa : the ANRS 12286/MOBIDIP trial
暂无分享,去创建一个
M. Peeters | E. Delaporte | S. Eymard-Duvernay | Suzanne Izard | G. Bado | J. Reynes | L. Ciaffi | A. Sawadogo | V. Moing | N. F. Guèye | M. Diallo | J. Zoungrana | S. Koulla‐Shiro | Avelin Aghokeng Fobang | P. Mbouyap | K. Kane